| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6175136 | European Urology | 2015 | 5 Pages |
Abstract
We found reduced efficacy of docetaxel, but not cabazitaxel, in enzalutamide-resistant prostate cancer.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Robert J. van Soest, Ellen S. de Morrée, Charlotte F. Kweldam, Corrina M.A. de Ridder, Erik A.C. Wiemer, Ron H.J. Mathijssen, Ronald de Wit, Wytske M. van Weerden,